Stevenage Bioscience Catalyst announces Marco Delise as new Entrepreneurship and Business Development Director

  • Published on 11th October 2022 by Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce that Marco Delise PhD is to join as Entrepreneurship and Business Development Director on 1st November 2022.

Dr Sally Ann Forsyth OBE, CEO at SBC said “With his extensive experience of innovation, research and fund raising for early-stage start-ups, Marco is ideally placed to support the growing cluster of exciting companies here at SBC. We are delighted to welcome him to the team and look forward to working with him in the future”.

Dr Marco Delise commented “I am delighted to be joining SBC at such an exciting time of growth for the campus. I very much look forward to working with Sally Ann and her team.”

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.